Literature DB >> 3611358

Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.

Y A Kesäniemi, C Ehnholm, T A Miettinen.   

Abstract

Relationship between the efficiency of cholesterol absorption and apolipoprotein E (apoE) phenotype was studied in a random sample of middle-aged Finnish men. Subjects that were either heterozygous or homozygous for the allele epsilon 2 absorbed less and synthesized more cholesterol than those with the phenotype E4/3 and E4/4, the values for the individuals with the most frequent phenotype E3/3 (56% of the population sample) falling in between. Among the whole study group, the sum of the subscripts of apoE phenotype (e.g., E2/3 = 5) was correlated positively with the fractional absorption of cholesterol (r = 0.40; P less than 0.05) and negatively with the serum level of lathosterol, a cholesterol precursor sterol reflecting the activity of cholesterol synthesis (r = -0.48; P less than 0.01). Thus, apoE polymorphism appears to affect the efficiency of cholesterol absorption and may by this mechanism contribute to the variation in plasma total and low density lipoprotein cholesterol concentration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611358      PMCID: PMC442272          DOI: 10.1172/JCI113107

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

3.  Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.

Authors:  V I Zannis; J L Breslow
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

4.  Human apolipoprotein E. The complete amino acid sequence.

Authors:  S C Rall; K H Weisgraber; R W Mahley
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

5.  Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column.

Authors:  T A Miettinen
Journal:  Clin Chim Acta       Date:  1982-09-15       Impact factor: 3.786

6.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.

Authors:  S K Basu; M S Brown; Y K Ho; R J Havel; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

Review 7.  The plasma lecithins:cholesterol acyltransferase reaction.

Authors:  J A Glomset
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

8.  Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E.

Authors:  R E Gregg; L A Zech; E J Schaefer; H B Brewer
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

9.  Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man.

Authors:  J R Crouse; S M Grundy
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

10.  Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins.

Authors:  T A Miettinen
Journal:  J Lipid Res       Date:  1982-03       Impact factor: 5.922

View more
  50 in total

1.  Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol.

Authors:  E Boerwinkle; S A Brown; K Rohrbach; A M Gotto; W Patsch
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

2.  Plasma noncholesterol sterols as indicators of cholesterol absorption.

Authors:  Scott M Grundy
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

3.  Distribution and effect of apo E genotype on plasma lipid and apolipoprotein profiles in overweight/obese and nonobese Chinese subjects.

Authors:  Juan Zhang; Ping Fan; Rui Liu; Yi Huang; Shanshan Liang; Yu Liu; Yin Wu; Huai Bai
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

4.  Association of Common Single Nucleotide Polymorphisms of Candidate Genes with Gallstone Disease: A Meta-Analysis.

Authors:  Tripty Chauhan; R D Mittal; B Mittal
Journal:  Indian J Clin Biochem       Date:  2019-05-15

5.  Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse.

Authors:  Curzio Solcà; Bhaswati Pandit; Hongwei Yu; G Stephen Tint; Shailendra B Patel
Journal:  Mol Genet Metab       Date:  2007-01-02       Impact factor: 4.797

6.  Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.

Authors:  Valerie Leduc; Lucienne Bourque; Judes Poirier; Robert Dufour
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

7.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

8.  APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

Authors:  Rafael O Alvim; Silvia R S Freitas; Noely E Ferreira; Paulo C J L Santos; Roberto S Cunha; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2010-11-08       Impact factor: 3.876

9.  Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.

Authors:  T Demant; D Bedford; C J Packard; J Shepherd
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 10.  Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes.

Authors:  David Q-H Wang; Nezam H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.